Week In Review: Shanghai Henlius To File For Hong Kong IPO At Valuation Of Over $1 Billion

Shanghai Fosun Pharma (HK: 02196: SHA: 600196) announced it will seek a Hong Kong IPO for Shanghai Henlius Biotech, its monoclonal antibody JV subsidiary. At the same time, the company will …
( read original story …)

Related Post